# Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk

> **NCT02757989** · NA · COMPLETED · sponsor: **Groupe Francophone des Myelodysplasies** · enrollment: 79 (actual)

## Conditions studied

- MDS

## Interventions

- **OTHER:** transplantation

## Key facts

- **NCT ID:** NCT02757989
- **Lead sponsor:** Groupe Francophone des Myelodysplasies
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-31
- **Primary completion:** 2024-06-07
- **Final completion:** 2024-06-07
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2024-08-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02757989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02757989, "Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02757989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*